← United States · Coverage record
US · SEC FORM 4
GE HealthCare Technologies Inc.
GEHC · Nasdaq · CIK 0001932393 · Healthcare · Medical Devices
INSIDER SIGNAL
8 buyers · 8 purchase transaction lines · $6.4M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Role scores low · most senior buyer: President and CEO (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Purchase breadth & concentration
Roles in the peak window: Chief Financial Officer, Director, GC & Corporate Secretary, President and CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 12 additional owner(s) remain in Form 4 evidence.
SIGNAL HISTORY
Latest recorded score
- 81.2
- 81.1
- 81.1
- 81.0
- 81.1
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- +2.3%
- 3M
- +0.7%
- 6M
- -10.2%
- 12M
- -12.5%
Volatility & liquidity
- Volatility
- 35.0%
- Beta
- —
- Avg daily value
- USD 270.3M
Valuation
- Market cap
- USD 29.7B
- P/E
- 14.2×
Fundamentals
- Profit margin
- 10.1%
- ROE
- 20.1%
- Industry
- Medical Devices
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-22 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 18,520,401
- Previous report
- 16,909,543
- Avg daily volume
- 3,962,319
- Days to cover
- 4.7
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Lobo Kevin | Purchase (P) | Common Stock, par value $0.01 per share | 10,000 | USD 64.18 | USD 641,800 | SEC filing ↗ |
| 2026-05-12 | Hochman Rodney F | Purchase (P) | Common Stock, par value $0.01 per share | 1,618 | USD 62.03 | USD 100,365 | SEC filing ↗ |
| 2026-05-08 | Yang Watkin Phoebe L. | Purchase (P) | Common Stock, par value $0.01 per share | 1,000 | USD 63.01 | USD 63,010 | SEC filing ↗ |
| 2026-05-06 | Stromberg William J | Purchase (P) | Common Stock, par value $0.01 per share | 1,000 | USD 61.69 | USD 61,690 | SEC filing ↗ |
| 2026-05-06 | CULP H LAWRENCE JR | Purchase (P) | Common Stock, par value $0.01 per share | 80,805 | USD 61.88 | USD 5,000,213 | SEC filing ↗ |
| 2026-05-01 | SACCARO JAMES | Purchase (P) | Common Stock, par value $0.01 per share | 3,310 | USD 60.60 | USD 200,586 | SEC filing ↗ |
| 2026-04-30 | Jimenez Frank R | Purchase (P) | Common Stock, par value $0.01 per share | 1,750 | USD 60.45 | USD 105,788 | SEC filing ↗ |
| 2026-04-30 | Arduini Peter J | Purchase (P) | Common Stock, par value $0.01 per share | 4,169 | USD 59.93 | USD 249,848 | SEC filing ↗ |
| 2024-05-01 | Jimenez Frank R | Purchase (P) | Common Stock, par value $0.01 per share | 1,315 | USD 76.52 | USD 100,624 | SEC filing ↗ |
| 2023-01-23 | CULP H LAWRENCE JR | Purchase (P) | Common Stock, par value $0.01 per share | 748 | USD 69.26 | USD 51,806 | SEC filing ↗ |
Form 4 evidence
77 transaction lines in the latest 365-day window; 323 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Grogan William K | Award / grant (A) | Common Stock, par value $0.01 per share | 75,096 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-03 | Rackliffe Philip | Tax withholding (F) | Common Stock, par value $0.01 per share | 798 | USD 70.56 | USD 56,307 | SEC filing ↗ |
| 2026-09-03 | O'Neill Kevin Michael | Tax withholding (F) | Common Stock, par value $0.01 per share | 718 | USD 70.56 | USD 50,662 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Grogan William K | Award / grant (A) | Common Stock, par value $0.01 per share | 75,096 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-03 | Rackliffe Philip | Tax withholding (F) | Common Stock, par value $0.01 per share | 798 | USD 70.56 | USD 56,307 | SEC filing ↗ |
| 2026-09-03 | O'Neill Kevin Michael | Tax withholding (F) | Common Stock, par value $0.01 per share | 718 | USD 70.56 | USD 50,662 | SEC filing ↗ |
| 2026-09-03 | Newcomb George A. | Tax withholding (F) | Common Stock, par value $0.01 per share | 112 | USD 70.56 | USD 7,903 | SEC filing ↗ |
| 2026-09-03 | Kass-Hout Taha | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,502 | USD 70.56 | USD 105,981 | SEC filing ↗ |
| 2026-09-03 | Jimenez Frank R | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,480 | USD 70.56 | USD 104,429 | SEC filing ↗ |
| 2026-09-03 | Holton Adam Y | Tax withholding (F) | Common Stock, par value $0.01 per share | 673 | USD 70.56 | USD 47,487 | SEC filing ↗ |
| 2026-09-03 | Estrampes Catherine | Tax withholding (F) | Common Stock, par value $0.01 per share | 508 | USD 70.56 | USD 35,844 | SEC filing ↗ |
| 2026-09-03 | Arduini Peter J | Tax withholding (F) | Common Stock, par value $0.01 per share | 6,303 | USD 70.56 | USD 444,740 | SEC filing ↗ |
| 2026-09-01 | Rackliffe Philip | Tax withholding (F) | Common Stock, par value $0.01 per share | 856 | USD 71.23 | USD 60,973 | SEC filing ↗ |
| 2026-09-01 | Kass-Hout Taha | Tax withholding (F) | Common Stock, par value $0.01 per share | 2,940 | USD 71.23 | USD 209,416 | SEC filing ↗ |
| 2026-09-01 | Jimenez Frank R | Tax withholding (F) | Common Stock, par value $0.01 per share | 3,131 | USD 71.23 | USD 223,021 | SEC filing ↗ |
| 2026-09-01 | Holton Adam Y | Tax withholding (F) | Common Stock, par value $0.01 per share | 659 | USD 71.23 | USD 46,941 | SEC filing ↗ |
| 2026-09-01 | Bankes Jeannette | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,064 | USD 71.23 | USD 75,789 | SEC filing ↗ |
| 2026-09-01 | Arduini Peter J | Tax withholding (F) | Common Stock, par value $0.01 per share | 11,515 | USD 71.23 | USD 820,213 | SEC filing ↗ |
| 2026-08-15 | Holton Adam Y | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,360 | USD 73.69 | USD 100,218 | SEC filing ↗ |
| 2026-05-22 | Lobo Kevin | Purchase (P) | Common Stock, par value $0.01 per share | 10,000 | USD 64.18 | USD 641,800 | SEC filing ↗ |
| 2026-05-15 | Rackliffe Philip | Award / grant (A) | Common Stock, par value $0.01 per share | 16,458 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-15 | Bankes Jeannette | Tax withholding (F) | Common Stock, par value $0.01 per share | 5,535 | USD 62.67 | USD 346,878 | SEC filing ↗ |
| 2026-05-12 | Hochman Rodney F | Purchase (P) | Common Stock, par value $0.01 per share | 1,618 | USD 62.03 | USD 100,365 | SEC filing ↗ |
| 2026-05-08 | Yang Watkin Phoebe L. | Purchase (P) | Common Stock, par value $0.01 per share | 1,000 | USD 63.01 | USD 63,010 | SEC filing ↗ |
| 2026-05-07 | Yang Watkin Phoebe L. | Award / grant (A) | Common Stock, par value $0.01 per share | 3,586 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-07 | Stromberg William J | Award / grant (A) | Common Stock, par value $0.01 per share | 3,586 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-07 | Madden Anne T | Award / grant (A) | Common Stock, par value $0.01 per share | 5,868 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-07 | Lobo Kevin | Award / grant (A) | Common Stock, par value $0.01 per share | 3,586 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-07 | LESJAK CATHERINE A | Award / grant (A) | Common Stock, par value $0.01 per share | 3,586 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-07 | Hochman Rodney F | Award / grant (A) | Common Stock, par value $0.01 per share | 6,275 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-07 | CULP H LAWRENCE JR | Award / grant (A) | Common Stock, par value $0.01 per share | 7,743 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-06 | Stromberg William J | Purchase (P) | Common Stock, par value $0.01 per share | 1,000 | USD 61.69 | USD 61,690 | SEC filing ↗ |
| 2026-05-06 | CULP H LAWRENCE JR | Purchase (P) | Common Stock, par value $0.01 per share | 80,805 | USD 61.88 | USD 5,000,213 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | GEHC |
| CIK | 0001932393 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 323 transaction lines from 2023-01-03 to 2026-09-14 10 P purchase lines · 13 S sale lines · 300 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.